{"entity":{"id":"ogyi-hungary","kind":"institution","name":"National Institute of Pharmacy of Hungary (Országos Gyógyszerészeti Intézet)","aka":["Országos Gyógyszerészeti Intézet","OGYI","OGYÉI","Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet","National Institute of Pharmacy and Nutrition"],"tldr":"Hungary's medicines authority. The work was done by OGYÉI until 2023, then by the National Centre for Public Health and Pharmacy, and from 1 November 2026 by a new National Institute of Pharmacy. New cancer medicines are authorised for the whole EU through the European Medicines Agency.","summary":"The National Centre for Public Health and Pharmacy (NNGYK) states that it was formed on 1 August 2023 when the National Institute of Pharmacy and Nutrition (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet, OGYÉI) merged into the National Public Health Centre, and that as an authority it was responsible for medicines supervision and the pharmaceutical market. Its notice of 3 November 2026 says that under Government Decree 324/2026 (X. 29.) the pharmaceutical tasks were split off on 1 November 2026 into the Országos Gyógyszerészeti Intézet (OGYI), a separate central office that is the legal successor for those tasks.\n\nNew active substances for cancer go through the EU centralised procedure, so they are authorised in Hungary at the same time as elsewhere in the EU. The OECD and European Commission's 2025 profile notes that since August 2023 the pharmacy authority has also carried out the mandatory health technology assessment of new medicines. The authority's medicines database and adverse reaction reporting site at ogyei.gov.hu were suspended from 22 to 26 October 2026 after a national cyber security alert, according to NNGYK.","asOf":"2026-11-11","links":[{"label":"NNGYK: rólunk (about us, with the November 2026 notice)","url":"https://nngyk.gov.hu/hu/rolunk.html"},{"label":"NNGYK: new name and the split of pharmaceutical tasks, 3 November 2026","url":"https://nngyk.gov.hu/hu/tovabbi-hirek/az-nngyk-uj-elnevezese-orszagos-nepegeszsegugyi-intezetre-oni.html"},{"label":"NNGYK: pharmacy websites temporarily unavailable, 22 October 2026","url":"https://nngyk.gov.hu/hu/tovabbi-hirek/tajekoztatas-gyogyszereszeti-honlapjaink-atmeneti-elerhetetlensegerol.html"},{"label":"OECD/EC: Country Cancer Profile Hungary 2025, section 5.1 (PDF)","url":"https://cancer-inequalities.jrc.ec.europa.eu/sites/default/files/docs/ccp2025/ec-oecd-hu-2024-1670-en.pdf"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ema","neak-hungary"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Budapest","country":"HU","lat":47.498,"lng":19.04,"institutionType":"government","website":"https://ogyei.gov.hu","programs":["Medicines supervision and authorisation","Health technology assessment of new medicines","Pharmacovigilance and adverse reaction reporting","Permits for medicines without a Hungarian marketing authorisation"]},"route":"/institutions/ogyi-hungary/","neighbours":{"institution":[{"id":"ema","kind":"institution","name":"European Medicines Agency","route":"/institutions/ema/"},{"id":"neak-hungary","kind":"institution","name":"National Health Insurance Fund of Hungary (Nemzeti Egészségbiztosítási Alapkezelő)","route":"/institutions/neak-hungary/"},{"id":"oni-hungary","kind":"institution","name":"National Institute of Public Health of Hungary (Országos Népegészségügyi Intézet)","route":"/institutions/oni-hungary/"}]}}